Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    16714187 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial
Conditions: Brain Ischemia;   Transient Ischemic Attack;   Arteriosclerosis
Interventions: Drug: anticoagulation;   Drug: aspirin and dipyridamole;   Drug: aspirin alone
2 Suspended Persantin Preceding Elective PCI
Conditions: Coronary Heart Disease;   Percutaneous Transluminal Coronary Angioplasty;   Atherosclerosis
Interventions: Drug: dipyridamole;   Drug: placebo

Indicates status has not been verified in more than two years